US-based NIRF Imaging and Exelis have joined forces to develop and market a near-infrared fluorescence imaging technology for point-of-care diagnostic applications.

Under the terms of agreement, Exelis will provide NIRF Imaging with its proprietary Pinnacle Gen III image intensifier (I2) tubes, which have historically been used primarily in military-grade night-vision goggles, for use as a key component in NIRF Imaging’s proprietary medical imaging technology.

According to the company, the ability to provide a ‘ready-now’ technology such as Pinnacle was a key factor in selecting Exelis as a partner.

The signing of this strategic alliance is the result of a long-term relationship between the two companies.

"The NIRF-LI system is expected to provide physicians and surgeons with a dynamic, non-invasive, point-of-care imaging system available for imaging the body’s lymphatic system, without the risks associated with radioactive imaging agents."

NIRF Imaging will use Exelis’ state-of-the-art image intensification technology as a key component in a proprietary medical imaging technology-based on near infrared fluorescence (NIRF) and micro-doses of nonradioactive dye in order to produce a new tool for imaging patients’ lymphatic system.

NIRF Imaging CEO Christopher Fashek said: "Not only is their image intensifier a key component of our technology, but also Exelis’s world-class reputation in innovation, design, quality and manufacturing will have a significant impact in helping us achieve our strategic initiatives."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Also, with NIRF technology development completed and validated in multiple clinical studies, NIRF Imaging and Exelis will finalise both the commercial design and manufacturing process for NIRF Imaging’s initial product, the NIRF-LI system.

The NIRF-LI system is expected to provide physicians and surgeons with a dynamic, non-invasive, point-of-care imaging system available for imaging the body’s lymphatic system, without the risks associated with radioactive imaging agents.

Exelis Night Vision business vice-president and general manager Dave Smith said: "NIRF Imaging represents an ideal expansion partner. Our image intensifier is a differentiating component in NIRF Technology and we look forward to deploying our commercialisation design, manufacturing resources and expertise to help NIRF Imaging address significant unmet needs within the global medical imaging market."